Related Experiment Videos
Low serum MMP-1 in breast cancer: a negative prognostic factor?
A Kulić1, N Dedić Plavetić, J Vrbanec
1Department of Pathophysiology, University Hospital Center Zagreb and Zagreb Medical School, Zagreb, Croatia. ana.kulic1@zg.t-com.hr
Abstract:
In this study we investigated the prognostic significance of serum matrix metalloproteinase (MMP)-1 levels in early-stage breast cancer patients and correlated these levels with various clinicopathologic parameters. MMP-1 levels were determined by enzyme-linked immunosorbent assay. MMP-1 serum levels in patients (n = 60) were significantly lower than in healthy subjects (n = 20, p < 0.0001). We found significant negative correlation between serum levels of MMP-1 and several negative prognostic factors of breast cancer. Kaplan-Meier analysis showed significantly shorter 5-year survival in patients with lower values of MMP-1 compared to those with high levels of MMP-1 (p = 0.0147). Our results suggest a negative prognostic role of low serum MMP-1.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation